Methylene Blue for the Treatment of COVID-19 in Pediatrics | ||
| Journal of Pediatric Perspectives | ||
| دوره 10، شماره 1، فروردین 2022، صفحه 15281-15284 اصل مقاله (309.34 K) | ||
| نوع مقاله: letter to the editor | ||
| شناسه دیجیتال (DOI): 10.22038/ijp.2021.59339.4625 | ||
| نویسندگان | ||
| Daryoush Hamidi Alamdari* 1؛ Bharat Bhushan2 | ||
| 1Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. | ||
| 2Covenant Medical Center and University Medical Center, Texas Tech University Health Science Center (TTUHSC) Lubbock, Texas, USA. | ||
| چکیده | ||
| Despite vaccination against SARS-CoV-2, the COVID-19 pandemic continues to expand worldwide. Early reports suggested that only a minor proportion of pediatric population is affected by COVID-19 in comparison to adult population. Three percent of pediatric population needed admission to intensive care units, and only a small number of deaths have been reported. Available literature suggests that infants (children under 1 year) seem to be more vulnerable to COVID-19 virus infection with a higher severity of illness compared with other pediatric ages. Requirement for neonatal mechanical ventilation is 20%–22.4% (vs. 4% in children) (1). | ||
| کلیدواژهها | ||
| COVID-19؛ Treatment؛ Methylene Blue؛ Pediatrics | ||
|
آمار تعداد مشاهده مقاله: 647 تعداد دریافت فایل اصل مقاله: 558 |
||